Answers are grounded in this paper and cite their sources.
Research reports the creation of an iPSC line to explore autism's genetic influence in a patient.
We report the generation of a human induced pluripotent stem cell (hiPSC) line from peripheral blood mononuclear cells of a 14-year-old male with Autism Spectrum Disorder carrying a de novo heterozygous likely-pathogenic variation c.4067C>T (p.Pro1356Leu) in Dynein Cytoplasmic 1 Heavy Chain 1 ( DYNC1H1 ) gene. Variation in this gene that encodes a motor protein may affect retrograde transport of neurotrophic signals, synaptic vesicles, organelles like golgi complex and mitochondria. Therefore, this iPSC line will be an invaluable tool to study the effects of this high-risk autism-related variant on disease manifestation and cellular functions.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: